Literature DB >> 6241700

Studies on the mechanism of tumor destruction by photoradiation therapy.

B W Henderson, T J Dougherty, P B Malone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241700

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  7 in total

1.  Phototherapy of posterior uveal melanomas.

Authors:  I Favilla; W R Barry; A Gosbell; P Ellims; F Burgess
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

Review 2.  Adjuvant therapy for pituitary adenomas: the possible role of photodynamic therapy.

Authors:  P V Marks
Journal:  Ann R Coll Surg Engl       Date:  1995-07       Impact factor: 1.891

3.  Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).

Authors:  Nadine S James; Penny Joshi; Tymish Y Ohulchanskyy; Yihui Chen; Walter Tabaczynski; Farukh Durrani; Masayuki Shibata; Ravindra K Pandey
Journal:  Eur J Med Chem       Date:  2016-06-29       Impact factor: 6.514

Review 4.  Photodynamic therapy--achievements and prospects.

Authors:  D Ash; S B Brown
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

Review 5.  Chlorin, Phthalocyanine, and Porphyrin Types Derivatives in Phototreatment of Cutaneous Manifestations: A Review.

Authors:  Sarah Raquel De Annunzio; Natalia Caroline Silva Costa; Rafaela Dalbello Mezzina; Márcia A S Graminha; Carla Raquel Fontana
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 6.  Photodynamic Therapy-Induced Acute Exudative Maculopathy (PAEM): Prevalence, Impact and Management Strategies.

Authors:  Andrew J Sumnicht; Kakarla V Chalam; David I Sierpina
Journal:  Clin Ophthalmol       Date:  2022-09-27

7.  Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model.

Authors:  L White; C J Gomer; D R Doiron; B C Szirth
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.